Clinical Trial Update: Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating Aurstat versus control for pruritus associated with atopic dermatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Pruritus

Drugs mentioned

• Aurstat

Snippet

Sponsor: The Center for Clinical and Cosmetic Research | Conditions: Pruritus, Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2022-10-24